What You Should Know
Axoft has raised an oversubscribed $55M Series A led by C.P. Group Innovation, bringing its total funding to over $60M.The capital will be used to expand global clinical trials, progress U.S. regulatory approval for its implantable Brain-Computer Interfaces (iBCIs), and build
Read More
Axoft Secures $55M for Implantable Brain-Computer Interfaces and Fleuron™ Material Global Trials































































